KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Current Taxes: 2017-2025

Historic Current Taxes for Sarepta Therapeutics (SRPT) over the last 3 years, with Sep 2025 value amounting to $9.1 million.

  • Sarepta Therapeutics' Current Taxes was N/A to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year change of. This contributed to the annual value of $17.4 million for FY2024, which is 26.33% up from last year.
  • As of Q3 2025, Sarepta Therapeutics' Current Taxes stood at $9.1 million, which was down 51.46% from $18.7 million recorded in Q2 2025.
  • Over the past 5 years, Sarepta Therapeutics' Current Taxes peaked at $79.9 million during Q1 2025, and registered a low of $216,000 during Q4 2021.
  • For the 3-year period, Sarepta Therapeutics' Current Taxes averaged around $24.3 million, with its median value being $18.3 million (2024).
  • Data for Sarepta Therapeutics' Current Taxes shows a peak YoY surged of 5,696.76% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' Current Taxes stood at $216,000 in 2021, then soared by 5,696.76% to $12.5 million in 2022, then climbed by 9.94% to $13.8 million in 2023, then grew by 26.33% to $17.4 million in 2024, then spiked by 336.61% to $9.1 million in 2025.
  • Its last three reported values are $9.1 million in Q3 2025, $18.7 million for Q2 2025, and $79.9 million during Q1 2025.